Supplementary Tables: Table S1 : Identification of 395 unique N-sialoglycosylation sites on cell surface proteins in HEK293T cells Table S2 : Identification of 128 unique sites on N-sialoglycoproteins in the secretome of HEK293T cells Table S3 : Identification of 1,120 N-sialoglycosylation sites on membrane proteins in HEK293T cells Table S4 : Identification of 541 N-sialoglycosylation sites on cell surface proteins of breast cancer cells Table S5 : N-sialoglycoproteins belonging to type I, II single-pass, multi-pass and peripheral membrane protein (UniProt) Table S7 : Quantification of 406 unique N-sialoglycopeptides on the cell surface of breast cancer cells Table S8 : Up-regulated N-sialoglycoproteins related to cell adhesion Table S9 : Domain analysis of up-regulated N-sialoglycoproteins in MDA-MB-231 cells Table S10 : Up-regulated N-sialoglycoproteins based on important domains Table S11 : Quantification of 342 N-sialoglycosylation sites on the cell surface of breast cancer cells MDA-MB-231, the triple negative breast cancer cell line was purchased from ATCC. All cell lines were cultured following the instructions provided by ATCC. HEK293T cells were incubated in DMEM until 40% confluency, then the medium was discarded and the monolayer was rinsed with PBS two times. The cells were further incubated in DMEM supplemented with 30 µM ManNAz or ManNAc for 24 hours 1 .
The labeling medium was collected and the cells were washed twice with PBS and incubated in PBS containing 200 µM DBCO-sulfo-biotin or DBCO-Fluor545 for 1 hour with gentle agitation at 4 °C. Cells were collected by centrifugation (5 minutes at 300 g) and washed with PBS twice. 
Sialoglycoprotein tagging and detection in cell lysates
HEK293T cells were seeded in T175 flasks and treated with the ManNAz or ManNAc (30 µM for 1 day) in DMEM. The cells were then harvested with nonenzymatic dissociation buffer; ~2×10 7 cells were collected and washed with PBS. Harvested cells were subjected to different click chemistry procedures.
For cell surface protein tagging, the cell pellets were washed twice with PBS and incubated in PBS containing 200 µM DBCO-Fluor545 for 1 hour with end-over-end rotation at 4 °C. For the membrane compartment tagging, the cell pellets were suspended in ice-cold buffer containing 100 mM HEPES (pH 7.5), 25 μg/mL digitonin, and protease inhibitor mixture (Roche Diagnostics), and then incubated with rotation at 4 °C for 10 minutes, followed by the centrifugation at 2,000 g to pellet the cells. The supernatant was discarded and the cell pellets were washed with ice-cold PBS twice. The purified cell pellets were incubated with 200 µM DBCO-Fluor545 in PBS for 1 hour at 4 °C. After the conjugation, cell pellets were washed with ice-cold PBS containing 10 mM DTT twice to remove and quench unreacted reagents. The pellets for surface protein detection were treated with digitonin then lysed in RIPA buffer (50 mM HEPES, pH=7.5, 150 mM NaCl, 0.1% SDS, protease inhibitors) and the pellets for membrane protein detection were lysed in RIPA directly. Protein concentrations were measured using the BCA protein assay (Pierce). To detect sialoglycoproteins in different cell extracts, ~20 µg of labeled or unlabeled protein lysate was resolved by SDS-PAGE. The Fluor545 signal and SimplyBlue staining bands were visualized and documented using a GE Typhoon Trio+ Fluorescence/Phospho-Imager system.
Cell lysis, protein extraction and digestion
The cell pellets were suspended in ice-cold buffer containing 100 mM HEPES, pH=7.5, 25 μg/ml digitonin, and protease inhibitor mixture (Roche Diagnostics); the cell suspension was rotated end-overend at 4 °C for 10 minutes and then centrifuged at 2,000 g to pellet the cells. The supernatant was discarded and the cell pellets were washed in ice-cold PBS twice. The cell pellets were resuspended in RIPA buffer with protease inhibitor cocktail and Benzonase (1 U/mL) and the suspension was incubated with shaking at 4 °C for 1 hour. After complete solubilization of nuclei and digestion of genomic DNA, the lysate was centrifuged at 25,000 g for 20 minutes. The supernatant was collected and proteins (about 2 mg total proteins for HEK293T cells, and about 10 mg for the SILAC experiment) were reduced by 5 mM DTT (56 °C, 25 min) and alkylated with 15 mM iodoacetamide (RT, 30 minutes in the dark). Proteins were purified by the methanol/chloroform precipitation method and resolublized in 50 mM HEPES (pH=8.2), 0.1 M urea, 5% ACN, digested with Lys-C (the ratio of Lys-C and protein was about 1:50) at 31ºC for 15 hours followed by trypsin digestion at 37 ºC for 4 hours. Digestion was quenched by the addition of 10% TFA to a final concentration of 0.4%, and the resulting peptides were purified using a Sep-Pak tC18 cartridge (Waters).
Biotinylated peptide enrichment and PNGase F treatment
The peptide mixture was dissolved in 100 mM PBS (pH=7.4), and incubated with the high capacity NeutrAvidin resin for one hour with rotation. After incubation, the beads were transferred into a spin column and washed five times with PBS and one time with Milli-Q water. Enriched peptides were eluted three times by incubation with 8 M guanidine (pH=1.5) at 56 ºC for 2 minutes each. The eluted peptides were purified using a Sep-Pak tC18 cartridge. The enriched samples were dried in a lyophilizer for at least 24 hours. The completely dried samples were dissolved in heavy-oxygen water containing 40 mM NH 4 HCO 3 and treated with PNGase F (lyophilized powder from Sigma Aldrich) at 37 ºC for 3 hours.
PNGase F removed glycans on Asn and as a result, Asn was converted to Asp with a tag of 18 O. The deglycosylated peptide samples were desalted again using a stage tip and eluted with three eluting solutions containing 20%, 50% and 80% ACN, respectively.
LC-MS/MS analysis
Purified and dried peptide samples were dissolved in a solvent with 5% ACN and 4% formic acid (FA), and 2 μL was loaded onto a microcapillary column packed with C18 beads (Magic C18AQ, 5 μm, 200 Å, 100 μm x 16 cm) using a WPS-3000TPLRS autosampler (UltiMate 3000 Thermostatted Pulled Loop Rapid Separation Wellplate Sampler, Dionex). Peptides were separated by reversed-phase chromatography using an UltiMate 3000 binary pump with a 90-minute gradient of 4-30% ACN (in 0.125% FA) and detected in a hybrid dual-cell quadrupole linear ion trap -Orbitrap mass spectrometer (LTQ Orbitrap Elite, ThermoFisher, with Xcalibur 3.0.63 software) using a data-dependent Top 20 method. 5 For each cycle, one full MS scan (resolution: 60,000) in the Orbitrap at 10 6 AGC target was followed by up to 20 MS/MS in the LTQ for the most intense ions. Selected ions were excluded from further analysis for 90 s each. Ions with a single or unassigned charge were not sequenced. Maximum ion accumulation times were 1000 ms for each full MS scan and 50 ms for each MS/MS scan.
Database searching and data filtering
The raw files recorded by MS were converted into mzXML format. Precursors for MS/MS fragmentation were checked for incorrect monoisotopic peak assignments while refining precursor ion mass measurements. 6 All MS/MS spectra were then searched using the SEQUEST algorithm (version 28). 7 Spectra were matched against a database encompassing sequences of all proteins in the UniProt Human The target-decoy method was employed to evaluate and further control FDRs of glycopeptide identification. 8, 9 Linear discriminant analysis (LDA) was utilized to distinguish correct and incorrect peptide identifications using numerous parameters such as XCorr, ΔCn, and precursor mass error. 6 This approach has been used in previous works [10] [11] [12] [13] . After scoring, peptides less than six amino acids in length were discarded and peptide spectral matches were filtered to a less than 1% FDR based on the number of decoy sequences in the final data set. The dataset was restricted to N-sialoglycopeptides when determining FDRs.
Glycosylation site localization
To assign glycosylation site localizations and measure the assignment confidence, we applied a probabilistic algorithm 14 that considers all potential glycosylation sites on a peptide and uses the presence or absence of experimental fragment ions unique to each to calculate a ModScore. The ModScore, which is similar to AScore, indicates the likelihood that the best site match is correct when compared with the next best match. This has also been used previously. 15, 16 We considered sites with a score ≥19 (P≤ 0.01) to be confidently localized.
Bioinformatic analysis
Membrane protein annotations were extracted from the UniProt database (Peripheral membrane protein 
Quantification of unique N-sialoglycopeptides and N-sialoglycosylation sites
Identified N-sialoglycopeptides in breast cancer cells with different invasiveness were quantified. In order to obtain accurate ratios, signal-to-noise (S/N) ratios for both heavy and light peptides were required to be larger than 3. If the S/N ratio for one (either heavy or light) peptide was lower than 3, the other one (light or heavy, respectively) was required to be larger than 5. In addition, if a glycopeptide is exclusively identified in one sample, the ratio reported here is not a real ratio, but the S/N ratio of the corresponding peptide. With the criteria of S/N being over 3, any quantified exclusive N-sialoglycopeptides must be upor down-regulated.
Based on the dataset of quantified unique N-sialoglycopeptides, we further performed the quantification of N-sialoglycosylation sites. It required that the quantified peptide contain only one site, and the ModScore was >19 to make sure the site was well-localized.
Domain analysis
Another two examples are shown in Figure S6 . PTPRJ (CD148) is receptor-type tyrosine-protein phosphatase eta, which dephosphorylates or contributes to the dephosphorylation of many proteins including EGFR, LYN, SRC, MAPK1, MAPK3 and TJP1. It plays a critical role in cell adhesion, migration, proliferation and differentiation, and is involved in the regulation of human T cell activation 20 .
This protein contains nine fibronectin type III domains in the extracellular part and one tyrosine phosphatase domain in the intracellular part. All 13 identified N-sialoglycosylation sites were located within the fibronectin type III domain. From the N-terminus, each of the first four domains contained at least two sialoglycosylation sites, and all three quantified sites were significantly up-regulated in invasive cells.
Another example is integrin alpha-3 (ITGA3, CD49c), which is a receptor for fibronectin, laminin, collagen, epiligrin, thrombospondin, and is involved in cell-matrix adhesion 21 . There are 14 predicted Nglycosylation sites listed on the UniProt website, and ten of them were identified in this work (N86, 107, 265, 511, 573, 605, 656, 697, 926 and 969). Seven sites were quantified and they were all highly upregulated with ratios ranging from 3.7 to 28.3 in MDA-MB-231 cells. The transmembrane region is from amino acid residue 992-1014, and the cytoplasmic region is from 1015-1051. Sialic acid bound to the terminus of the N-glycans at these sites can dramatically increase the water solubility and cause proteins to carry more negative charges under physiological conditions, which will result in decreased cell adhesion and increased cell invasiveness and migration. 
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